 |
|
|
| |
Pharmacokinetics of Cabotegravir in Subjects With Moderate Hepatic Impairment
|
| |
| |
Reported by Jules Levin
IDWeek 2017™; October 4-8, 2017; San Diego, CA
Jafar Sadik B. Shaik,1Susan L. Ford,2Yu Lou,3Zhiping Zhang,3Kalpana K. Bakshi,4Allan R. Tenorio,5Christine Trezza,5William R. Spreen,5Parul Patel5
1GlaxoSmithKline, Upper Merion, PA; 2GlaxoSmithKline, Research Triangle Park, NC; 3PAREXEL International, Durham, NC; 4GlaxoSmithKline, Collegeville, PA; 5ViiV Healthcare, Research Triangle Park, NC
|
| |
|
|
|
|
|
